The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

This agreement includes the program required for the approval of mesdopetam as a treatment for levodopa-induced dyskinesia (LIDs) in patients with Parkinson's disease. EMA has reviewed the ...

Jersey County Treasurer Katie Abbey has been under investigation by the Illinois State Police Public Integrity Unit since at least October of 2024, after allegations surfaced of her misappropriation ...

This agreement includes the program required for the approval of mesdopetam as a treatment for levodopa-induced dyskinesia (LIDs) in patients with Parkinson's disease. EMA has reviewed the ...